GlobeNewswire - News from Massachusetts Contains the last 20 releases uuid:05bceb19-93b6-4cc9-8636-0e0694d3265f;id=1827 2021-02-27T02:30:00Z newsdesk@globenewswire.com (NewsDesk) http://www.yebxqs.cn/LegacyRss?Length=4 newsdesk@globenewswire.com http://www.yebxqs.cn/news-release/2021/02/27/2183782/0/en/Imara-to-Webcast-Conference-Call-of-Full-Year-2020-Financial-Results-and-Business-Highlights.html Imara to Webcast Conference Call of Full Year 2020 Financial Results and Business Highlights 2021-02-27T02:30:00Z 2021-02-27T09:33:11Z BOSTON, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin, today announced that the company will host a conference call and live webcast on Friday, March 5, 2021 at 8:30 a.m. ET to discuss its financial results for the year ended December 31, 2020 and review recent business highlights.

]]>
2183782 en GlobeNewswire Inc. Imara, Inc. Sat, 27 Feb 2021 02:31 GMT Calendar of Events
http://www.yebxqs.cn/news-release/2021/02/27/2183767/0/en/Sarepta-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 2021-02-27T00:12:46Z 2021-02-27T09:33:11Z CAMBRIDGE, Mass., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on Feb. 26, 2021 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta’s 2014 Employment Commencement Incentive Plan, as a material inducement to employment to 2 individuals hired by Sarepta in February 2021. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).

]]>
2183767 en GlobeNewswire Inc. Sarepta Therapeutics, Inc. Sat, 27 Feb 2021 00:13 GMT Company Announcement
http://www.yebxqs.cn/news-release/2021/02/26/2183708/0/en/CPS-Technologies-Corporation-Conference-Call-Replay.html CPS Technologies Corporation Conference Call Replay 2021-02-26T21:10:02Z 2021-02-27T09:33:11Z NORTON, Mass., Feb. 26, 2021 (GLOBE NEWSWIRE) -- CPS Technologies Corporation (NASDAQ:CPSH) has posted the recording of its February 24, 2021 Investor Call on its website. A brief summary of the call including the minute and second mark in which specific topics are discussed appears below.

]]>
2183708 en GlobeNewswire Inc. CPS Technologies Corp. Fri, 26 Feb 2021 21:10 GMT Calendar of Events
http://www.yebxqs.cn/news-release/2021/02/26/2183652/0/en/ReWalk-Robotics-Announces-Closing-of-40-0-Million-Private-Placement-Priced-At-the-Market.html ReWalk Robotics Announces Closing of $40.0 Million Private Placement Priced At-the-Market 2021-02-26T17:41:59Z 2021-02-27T09:33:11Z MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Feb. 26, 2021 (GLOBE NEWSWIRE) -- ?ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced the closing of its previously announced private placement of 10,921,502 ordinary shares and warrants to purchase up to 5,460,751 ordinary shares, at a purchase price of $3.6625 per share and associated warrant, that was priced “at-the-market” under Nasdaq rules and resulted in gross proceeds of approximately $40.0 million before the deduction of placement agent fees and expenses and estimated offering expenses payable by the Company. The warrants have a term of five and one-half years, are exercisable immediately and have an exercise price of $3.60 per ordinary share.

]]>
2183652 en GlobeNewswire Inc. ReWalk Robotics Ltd. Fri, 26 Feb 2021 17:42 GMT Financing Agreements
http://www.yebxqs.cn/news-release/2021/02/26/2183489/0/en/Kaspersky-shares-state-of-stalkerware-in-2020.html Kaspersky shares state of stalkerware in 2020 2021-02-26T14:02:00Z 2021-02-27T09:33:11Z Woburn, MA, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Today Kaspersky released “The State of Stalkerware 2020” report, which captures the incidence of the secret surveillance software often used in cases of domestic violence. The report found that 53,870 mobile users were affected globally by stalkerware in 2020. The figure is a slight drop from the year before, when 67,500 mobile users were affected, but the yearly curve began to rise again in the second half of 2020, after some lockdown measures were lifted.

]]>
2183489 en GlobeNewswire Inc. Kaspersky Fri, 26 Feb 2021 14:02 GMT Company Announcement
http://www.yebxqs.cn/news-release/2021/02/26/2183487/0/en/Innovation-Pharma-Provides-Study-Details-for-Ongoing-Phase-2-Clinical-Trial-of-Brilacidin-in-Hospitalized-COVID-19-Patients.html Innovation Pharma Provides Study Details for Ongoing Phase 2 Clinical Trial of Brilacidin in Hospitalized COVID-19 Patients 2021-02-26T14:00:00Z 2021-02-27T09:33:11Z WAKEFIELD, Mass., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today provides additional study details for its ongoing Phase 2 clinical trial assessing Brilacidin as a novel therapeutic in hospitalized patients with COVID-19. Patients are being treated, with recruitment and enrollment progressing at trial sites.

]]>
2183487 en GlobeNewswire Inc. Innovation Pharmaceuticals Inc. Fri, 26 Feb 2021 14:01 GMT Product / Services Announcement Research Analysis and Reports clinical trials SARS-CoV-2 strains COVID-19
http://www.yebxqs.cn/news-release/2021/02/26/2183426/0/en/Albireo-Spotlights-Global-Patient-Communities-on-Rare-Disease-Day.html Albireo Spotlights Global Patient Communities on Rare Disease Day 2021-02-26T13:30:00Z 2021-02-27T09:33:11Z – Calls to unite global communities affected by rare diseases –

]]>
2183426 en GlobeNewswire Inc. Albireo Pharma, Inc. Fri, 26 Feb 2021 13:30 GMT Company Announcement
http://www.yebxqs.cn/news-release/2021/02/26/2183311/0/en/uniQure-to-Participate-in-Multiple-Upcoming-Industry-Conferences-in-March.html uniQure to Participate in Multiple Upcoming Industry Conferences in March 2021-02-26T12:05:00Z 2021-02-27T09:33:11Z LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Feb. 26, 2021 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced its participation in the following upcoming virtual investor and scientific conferences:

]]>
2183311 en GlobeNewswire Inc. uniQure Inc. Fri, 26 Feb 2021 12:05 GMT Calendar of Events uniQure gene therapy Conferences March March
http://www.yebxqs.cn/news-release/2021/02/26/2183289/0/en/Fulcrum-Therapeutics-to-Host-Fourth-Quarter-and-Full-Year-2020-Financial-Results-Conference-Call-and-Webcast-on-Thursday-March-4-2021-at-8-00-a-m-ET.html Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Webcast on Thursday, March 4, 2021 at 8:00 a.m. ET 2021-02-26T12:00:00Z 2021-02-27T09:33:11Z CAMBRIDGE, Mass., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.?(Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that its fourth quarter and full year 2020 financial results will be released on Thursday, March 4, 2021 before the U.S. financial markets open. Management will host a conference call and webcast at 8:00 a.m. ET to discuss the results and provide an update on recent corporate developments.

]]>
2183289 en GlobeNewswire Inc. Fulcrum Therapeutics Fri, 26 Feb 2021 12:00 GMT Calendar of Events
http://www.yebxqs.cn/news-release/2021/02/26/2183291/0/en/Fulcrum-Therapeutics-Recognizes-Rare-Disease-Day-2021.html Fulcrum Therapeutics Recognizes Rare Disease Day 2021 2021-02-26T12:00:00Z 2021-02-27T09:33:11Z Theme of global unity highlights critical role of building communities of support for patients and families affected by rare diseases around the world]]> 2183291 en GlobeNewswire Inc. Fulcrum Therapeutics Fri, 26 Feb 2021 12:00 GMT Calendar of Events http://www.yebxqs.cn/news-release/2021/02/26/2183299/0/en/Agios-Recognizes-14th-Annual-Rare-Disease-Day-and-Raises-Awareness-of-Unmet-Needs-in-Rare-Hemolytic-Anemias.html Agios Recognizes 14th Annual Rare Disease Day and Raises Awareness of Unmet Needs in Rare Hemolytic Anemias 2021-02-26T12:00:00Z 2021-02-27T09:33:11Z – In Partnership with the Sickle Cell Community Consortium, Agios Works to Address Educational Resource Gaps Caused by COVID-19 for Students with Sickle Cell Disease –

]]>
2183299 en GlobeNewswire Inc. Agios Pharmaceuticals, Inc. Fri, 26 Feb 2021 12:01 GMT Calendar of Events Health
http://www.yebxqs.cn/news-release/2021/02/26/2183302/0/en/DraftKings-Reports-Fourth-Quarter-and-Full-Year-2020-Results-and-Raises-2021-Revenue-Guidance.html DraftKings Reports Fourth Quarter and Full-Year 2020 Results and Raises 2021 Revenue Guidance 2021-02-26T12:00:00Z 2021-02-27T09:33:11Z Reports Fourth Quarter Revenue of $322 million; Increases 2021 Revenue Guidance to $900 million to $1 billion]]> 2183302 en GlobeNewswire Inc. DraftKings Inc. Fri, 26 Feb 2021 12:01 GMT Calendar of Events Earnings Releases and Operating Results http://www.yebxqs.cn/news-release/2021/02/26/2183239/0/en/Mersana-Therapeutics-Announces-Fourth-Quarter-and-Full-Year-2020-Financial-Results-and-Provides-Business-Update.html Mersana Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update 2021-02-26T11:00:00Z 2021-02-27T09:33:11Z - UPLIFT, a single-arm registration strategy evaluating upifitamab rilsodotin (UpRi) in platinum-resistant ovarian cancer, on track to begin in Q1 2021

]]>
2183239 en GlobeNewswire Inc. Mersana Therapeutics, Inc. Fri, 26 Feb 2021 11:00 GMT Earnings Releases and Operating Results
http://www.yebxqs.cn/news-release/2021/02/25/2183038/0/en/SHAREHOLDER-ALERT-Tricida-Inc-Sued-for-Violations-of-the-Federal-Securities-Laws-Investors-Should-Contact-Block-Leviton-LLP.html SHAREHOLDER ALERT: Tricida, Inc. Sued for Violations of the Federal Securities Laws; Investors Should Contact Block & Leviton LLP 2021-02-25T22:34:36Z 2021-02-27T09:33:11Z BOSTON, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Nationally-recognized securities law firm Block & Leviton LLP (www.blockleviton.com) announces that a lawsuit for violation of the federal securities laws has been filed against Tricida, Inc. (NASDAQ: TCDA) and certain of its executives.

]]>
2183038 en GlobeNewswire Inc. Block & Leviton LLP Thu, 25 Feb 2021 22:35 GMT Class Action Company Announcement Class Action
http://www.yebxqs.cn/news-release/2021/02/25/2182978/0/en/LeMaitre-Q4-2020-Financial-Results.html LeMaitre Q4 2020 Financial Results 2021-02-25T21:15:00Z 2021-02-27T09:33:11Z BURLINGTON, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2020 results and announced an $0.11/share quarterly dividend.

]]>
2182978 en GlobeNewswire Inc. LeMaitre Vascular, Inc. Thu, 25 Feb 2021 21:15 GMT Earnings Releases and Operating Results Finaincial Results EARNINGS LeMaitre Vascular
http://www.yebxqs.cn/news-release/2021/02/25/2182939/0/en/Vicor-Corporation-Reports-Results-for-the-Fourth-Quarter-and-Year-Ended-December-31-2020.html Vicor Corporation Reports Results for the Fourth Quarter and Year Ended December 31, 2020 2021-02-25T21:05:00Z 2021-02-27T09:33:11Z ANDOVER, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Vicor Corporation (NASDAQ: VICR) today reported financial results for the fourth quarter ended December 31, 2020.??

]]>
2182939 en GlobeNewswire Inc. Vicor Corporation Thu, 25 Feb 2021 21:06 GMT Earnings Releases and Operating Results
http://www.yebxqs.cn/news-release/2021/02/25/2182957/0/en/Ziopharm-Oncology-Provides-Leadership-and-Corporate-Updates-Reports-Fourth-Quarter-and-Full-Year-2020-Financial-Results.html Ziopharm Oncology Provides Leadership and Corporate Updates; Reports Fourth Quarter and Full Year 2020 Financial Results 2021-02-25T21:05:00Z 2021-02-27T09:33:11Z Heidi Hagen Appointed Interim Chief Executive Officer Replacing Dr. Laurence Cooper; Search for Permanent CEO Initiated

]]>
2182957 en GlobeNewswire Inc. ZIOPHARM Oncology Inc Thu, 25 Feb 2021 21:06 GMT Earnings Releases and Operating Results
http://www.yebxqs.cn/news-release/2021/02/25/2182958/0/en/Translate-Bio-Announces-Fourth-Quarter-and-Full-Year-2020-Financial-Results-and-Highlights-Recent-Progress.html Translate Bio Announces Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Progress 2021-02-25T21:05:00Z 2021-02-27T09:33:11Z -- Additional interim data expected in early Q2 from Phase 1/2 clinical trial of MRT5005 for the treatment of cystic fibrosis (CF) --

-- Two infectious disease mRNA vaccine programs expected to enter clinic in 2021: COVID-19 in Q1 and influenza in mid-2021, in collaboration with partner Sanofi Pasteur --

]]>
2182958 en GlobeNewswire Inc. Translate Bio, Inc. Thu, 25 Feb 2021 21:06 GMT Earnings Releases and Operating Results TBIO Translate Bio messenger RNA mRNA CF Cystic Fibrosis mRNA vaccine COVID-19 Financial Results
http://www.yebxqs.cn/news-release/2021/02/25/2182887/0/en/Voyager-Therapeutics-Announces-Fourth-Quarter-and-Full-Year-2020-Financial-Results-and-Corporate-Updates.html Voyager Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Corporate Updates 2021-02-25T21:01:00Z 2021-02-27T09:33:11Z CAMBRIDGE, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases, today reported its fourth quarter and full year 2020 financial results and provided corporate updates.

]]>
2182887 en GlobeNewswire Inc. Voyager Therapeutics, Inc. Thu, 25 Feb 2021 21:02 GMT Earnings Releases and Operating Results
http://www.yebxqs.cn/news-release/2021/02/25/2182889/0/en/Collegium-Reports-Record-Full-Year-2020-Revenue-of-310-0-Million.html Collegium Reports Record Full-Year 2020 Revenue of $310.0 Million 2021-02-25T21:01:00Z 2021-02-27T09:33:11Z – 2020 First Full-Year of Profitability, Driven by Xtampza? ER Revenue Growth and the Nucynta? Acquisition –

]]>
2182889 en GlobeNewswire Inc. Collegium Pharmaceutical, Inc. Thu, 25 Feb 2021 21:02 GMT Earnings Releases and Operating Results
粉色午夜视频/色戒未删减版在线观看视频/44383x3全国最大的免费观看/冲田杏梨番号